Moreover, we and others have demonstrated that chemotherapeutic drugs used as treatment in the context of MM, act via the activation of the intrinsic mitochondrial apoptotic pathway, usually in a p53-dependent manner [25, 26]. This evidence concerns the gene TP53 and Miyoshi myopathy.